Martin D. Berger
Martin D. Berger
MD, Professor, Department of Medical Oncology, Inselspital, University Hospital Bern
Verified email at
Cited by
Cited by
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
F Pagčs, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ...
The Lancet 391 (10135), 2128-2139, 2018
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation–a target for novel cancer therapy
R Tokunaga, WU Zhang, M Naseem, A Puccini, MD Berger, S Soni, ...
Cancer treatment reviews 63, 40-47, 2018
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
E Domingo, L Freeman-Mills, E Rayner, M Glaire, S Briggs, L Vermeulen, ...
The lancet Gastroenterology & hepatology 1 (3), 207-216, 2016
Tumour budding in solid cancers
A Lugli, I Zlobec, MD Berger, R Kirsch, ID Nagtegaal
Nature Reviews Clinical Oncology 18 (2), 101-115, 2021
Outlooks on Epstein-Barr virus associated gastric cancer
M Naseem, A Barzi, C Brezden-Masley, A Puccini, MD Berger, ...
Cancer treatment reviews 66, 15-22, 2018
Multicenter international society for immunotherapy of cancer study of the consensus immunoscore for the prediction of survival and response to chemotherapy in stage III colon …
B Mlecnik, C Bifulco, G Bindea, F Marliot, A Lugli, JJ Lee, I Zlobec, TT Rau, ...
Journal of Clinical Oncology 38 (31), 3638, 2020
B cell and B cell-related pathways for novel cancer treatments
R Tokunaga, M Naseem, JH Lo, F Battaglin, S Soni, A Puccini, MD Berger, ...
Cancer treatment reviews 73, 10-19, 2019
Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study
VH Koelzer, I Zlobec, MD Berger, G Cathomas, H Dawson, K Dirschmid, ...
Virchows Archiv 466, 485-493, 2015
Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy …
MD Berger, B Gerber, K Arn, O Senn, U Schanz, G Stussi
Haematologica 97 (1), 116, 2012
TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer
JA Galván, M Helbling, VH Koelzer, MP Tschan, MD Berger, M Hädrich, ...
Oncotarget 6 (2), 874, 2015
Stromal PD-1/PD-L1 expression predicts outcome in colon cancer patients
J Wyss, B Dislich, VH Koelzer, JA Galván, H Dawson, M Hädrich, ...
Clinical colorectal cancer 18 (1), e20-e38, 2019
Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer
R Tokunaga, J Xiu, C Johnston, RM Goldberg, PA Philip, A Seeber, ...
Clinical Cancer Research 25 (10), 3096-3103, 2019
Colorectal cancer: epigenetic alterations and their clinical implications
A Puccini, MD Berger, M Naseem, R Tokunaga, F Battaglin, S Cao, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1868 (2), 439-448, 2017
CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival
VH Koelzer, A Lugli, H Dawson, M Hädrich, MD Berger, M Borner, ...
Journal of translational medicine 12, 1-11, 2014
Comprehensive genomic profiling of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)
A Puccini, K Poorman, ME Salem, D Soldato, A Seeber, RM Goldberg, ...
Clinical Cancer Research 26 (22), 5943-5951, 2020
Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer
H Dawson, F Galuppini, P Träger, MD Berger, P Studer, L Brügger, ...
Human pathology 85, 145-151, 2019
CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway
J Graule, K Uth, E Fischer, I Centeno, JA Galván, M Eichmann, TT Rau, ...
Clinical epigenetics 10, 1-12, 2018
Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients
Y Ning, W Zhang, DL Hanna, D Yang, S Okazaki, MD Berger, Y Miyamoto, ...
The pharmacogenomics journal 18 (1), 29-34, 2018
Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer
G Rieger, VH Koelzer, HE Dawson, MD Berger, M Hädrich, D Inderbitzin, ...
Histopathology 70 (7), 1044-1051, 2017
Tumour budding and its clinical implications in gastrointestinal cancers
I Zlobec, MD Berger, A Lugli
British journal of cancer 123 (5), 700-708, 2020
The system can't perform the operation now. Try again later.
Articles 1–20